ArticleBMC pregnancy and childbirth2025
GLIS3 rs7034200 and ADRB3 rs4994 genetic variants associated with an increased risk of gestational diabetes mellitus in Chinese women: a case-control study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of GCKR and GLIS3 gene polymorphisms with gestational diabetes mellitus: A case-control study.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundGestational diabetes mellitus (GDM) has a complicated pathophysiology originating from interactions between susceptibility genes and adverse environmental factors. The transcription factor GLI-similar 3 (GLIS3) rs7034200C/A and adrenergic receptor beta 3 (ADRB3) rs4994T/C (Trp64Arg) polymorphisms are closely related to glucolipid metabolism, insulin resistance, obesity, and increased risk of type 2 diabetes. However, the association of these two polymorphisms with GDM in Chinese remains unknown. Therefore, this study explored the relationship between these two genetic variants and the risk of GDM, and assessed the effects of genotypes on glucolipid metabolism, oxidative stress, and clinical indicators.
methodsThis case-control study included 701 women with GDM and 1034 controls. The rs7034200C/A and rs4994T/C variants were genotyped using polymerase chain reaction-restriction fragment length polymorphism method. Clinical and biochemical parameters were analyzed.
resultsThe GLIS3 rs7034200C/A polymorphism was associated with an elevated risk of GDM according to the genotype, allele, dominant, and recessive genetic models (P < 0.05). After correcting for maternal age, pre-pregnancy BMI, and gestational age at sampling, the dominant and recessive models retained statistical significance in the binary logistic regression models (odds ratio [OR] = 1.268 and 1.334, 95% confidence interval [CI]: 1.017-1.580 and 1.020-1.745, respectively; P < 0.05) ; the AA genotype showed a higher risk for GDM, with the CC genotype as the reference, in a multinomial logistic regression model (OR = 1.519, 95% CI: 1.120-2.061; P = 0.007). No significant discrepancies were observed in the ADRB3 rs4994T/C polymorphism based on different genetic models (P > 0.05). However, the AA/TT combined genotype of the GLIS3 rs7034200C/A and ADRB3 rs4994T/C polymorphisms was associated with an elevated risk of GDM, with the CC/TT combined genotype as a reference (OR = 1.708, 95% CI: 1.191-2.450; P = 0.004). Furthermore, the GLIS3 rs7034200C/A variant significantly affected oxidative stress, insulin resistance, and glucolipid metabolism.
conclusionsThe A allele and AA genotype of the GLIS3 rs7034200C/A polymorphism, along with the AA/TT combined genotype of the GLIS3 rs7034200C/A and ADRB3 rs4994T/C variants, are genetic risk factors for GDM in Chinese women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.